Lirui Min (利锐敏)利锐敏

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

天麻素是一种在国家药监局注册认定的药品。该药品含有天麻素-d30891ea等成分。

该药品关联的活性成分包括:天麻素Tianma Su。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:山东罗欣药业集团股份有限公司Chinese legal name: 山东罗欣药业集团股份有限公司。

您可以探索含有相同成分的其他药品:天麻素-d30891ea成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 利锐敏) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 天麻素Tianma Su.

Manufacturers recorded for this product: 山东罗欣药业集团股份有限公司Chinese legal name: 山东罗欣药业集团股份有限公司.

Explore other medicines containing the same ingredient: 天麻素 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 利锐敏Recorded Chinese name: 利锐敏
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 0.1g(以天麻素计)Recorded Chinese specification

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 山东罗欣药业集团股份有限公司Chinese legal name: 山东罗欣药业集团股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20050723

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20050723

Manufacturer

Chinese legal name: 山东罗欣药业集团股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20050723

生产企业

山东罗欣药业集团股份有限公司(国产)

适应症

1.本品用于神经衰弱、神经衰弱综合症及脑外伤性综合症;|2.偏头痛,三叉神经痛,枕骨大神经痛、眩晕、突发性耳聋,前庭神经元炎,椎基底动脉供血不足及辅助治疗癫痫。

用法用量

1.肌内注射,使用前用注射用水溶解,一次0.2g(0.1g:2瓶/0.2g:1瓶),一日1~2次。|2.器质性疾病可适当增加剂量,或遵医嘱。

不良反应

不良反应轻微,有少数病人出现口鼻干燥、头昏、胃不适等症状,但不致影响病人接受用药,也无需特殊处理。

禁忌

对本品中任何成份过敏者禁用。

注意事项

1.使用本品期间,如出现任何不良事件和/或不良反应,请咨询医生。|2.同时使用其他药品,请告知医生。请放置儿童不能触及之处。

贮藏

密闭保存 。

规格

0.1g(以天麻素计)

证据Evidence

  • 批准文号: 国药准字H20050723
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.